Deal-Making

A profile view of an a human eye, highlighting the retina
Deal-Making
Axovia teams with Viralgen to manufacture BBS gene therapyAxovia teams with Viralgen to manufacture BBS gene therapy

The companies will rely on AskBio’s Pro10 manufacturing platform to target retinal degeneration.

byJosh Abbott, Editor, BioProcess Insider
Jan 22, 2025
|
1 Min Read
thumbnail
Deal-Making
Iconovo taps Lonza for spray-dried obesity biologicIconovo taps Lonza for spray-dried obesity biologic
byShreeyashi Ojha
Jan 20, 2025
1 Min Read
thumbnail
Deal-Making
Samsung Bio lands $1.4bn contract with undisclosed EU clientSamsung Bio lands $1.4bn contract with undisclosed EU client
byShreeyashi Ojha
Jan 16, 2025
1 Min Read
A person holds a magnifying glass over stylized representation of DNA
Therapeutic Class
Casgevy and beyond: Allogeneic therapies take spotlight for CRISPR TherapeuticsCasgevy and beyond: Allogeneic therapies take spotlight for CRISPR Therapeutics
byJosh Abbott
Jan 15, 2025
1 Min Read
thumbnail
Deal-Making
Boehringer bolsters ADC biz with $1.3bn Synaffix dealBoehringer bolsters ADC biz with $1.3bn Synaffix deal
byShreeyashi Ojha
Jan 13, 2025
1 Min Read
laboratory equipment
Deal-Making
Samsung Bio extends ADC partnership with LigaChemSamsung Bio extends ADC partnership with LigaChem
byJosh Abbott
Jan 10, 2025
1 Min Read
Image shows an outsourcing sign
Deal-Making
Contract catch-up: The latest cross-modality CDMO deals
Contract catch-up: The latest cross-modality CDMO deals
Jan 10, 2025
|
1 Min Read
byDan Stanton, Editorial director
Image of two jigsaw puzzle pieces fitting together
Deal-Making
Roche buys Poseida in $1.5bn acquisition
Roche buys Poseida in $1.5bn acquisition
Jan 9, 2025
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
WuXi selling cell therapy unit as BIOSECURE continues to play out
WuXi selling cell therapy unit as BIOSECURE continues to play out
Jan 6, 2025
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
SK pharmteco secures $1.4bn GLP-1 deal
SK pharmteco secures $1.4bn GLP-1 deal
Dec 19, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
MilliporeSigma to acquire Netherlands-based organoid pioneer HUB
MilliporeSigma to acquire Netherlands-based organoid pioneer HUB
Dec 18, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Facilities & Capacity
Israeli biomanufacturer Scinai expands into US with CDMO subsidiary
Israeli biomanufacturer Scinai expands into US with CDMO subsidiary
Dec 18, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Asahi strengthens autoimmune focus with Chiome partnership
Asahi strengthens autoimmune focus with Chiome partnership
Dec 16, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Novo expands EU footprint with $200m Novavax plant
Novo expands EU footprint with $200m Novavax plant
Dec 5, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
ATI and KBI team up to manufacture antagonistic antibody candidate
ATI and KBI team up to manufacture antagonistic antibody candidate
Dec 5, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Intas acquires Udenyca from Coherus BioSciences in potential $558 million deal
Intas acquires Udenyca from Coherus BioSciences in potential $558 million deal
Dec 5, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Big Pharma, big CGT deals: Roche buying Poseida, Novartis buys Kate
Big Pharma, big CGT deals: Roche buying Poseida, Novartis buys Kate
Dec 2, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
Halozyme’s $2.1bn Evotec bid: First the ins, now the out
Halozyme’s $2.1bn Evotec bid: First the ins, now the out
Nov 25, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
CDMO success stories: News from Lonza, Samsung Bio, Fujifilm
CDMO success stories: News from Lonza, Samsung Bio, Fujifilm
Nov 21, 2024
|
1 Min Read
byDan Stanton, Editorial director
Facilities & Capacity
Affinia and Forge team up to tackle cardiovascular diseases
Affinia and Forge team up to tackle cardiovascular diseases
Nov 15, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Therapeutic Class
Meitheal adds three biosimilars to US offering with new agreement
Meitheal adds three biosimilars to US offering with new agreement
Nov 13, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Novo taps Ascendis in $285m GLP-1 deal
Novo taps Ascendis in $285m GLP-1 deal
Nov 13, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
PE to buy CDMO Avid Bioservices for $1.1 billion
PE to buy CDMO Avid Bioservices for $1.1 billion
Nov 7, 2024
|
1 Min Read
byDan Stanton, Editorial director
Deal-Making
Chime partners with MedPacto for biologic manufacturing
Chime partners with MedPacto for biologic manufacturing
Nov 4, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Oct 30, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Regulations
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
Oct 18, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Cellular Origins and Fresenius Kabi partner to drive automation in CGT manufacturing
Oct 16, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
ReiThera partners with Sabin to send Marburg vaccine to Rwanda
Oct 14, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Opencell and Adva partnership seeks to improve CGT manufacturing
Opencell and Adva partnership seeks to improve CGT manufacturing
Oct 9, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Recipharm and Exela collaborate to boost US sterile injectable production
Recipharm and Exela collaborate to boost US sterile injectable production
Oct 9, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Xcellbio and AmplifyBio partner to advance cell-therapy development
Xcellbio and AmplifyBio partner to advance cell-therapy development
Oct 8, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Dark Horse bolsters CGT consulting outreach with BioTechLogic acquisition
Oct 4, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Amid BIOSECURE Act, WuXi Apptec and WuXi Biologics explore selling assets
Oct 3, 2024
|
1 Min Read
byJosh Abbott, Editor, BioProcess Insider
Deal-Making
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Oct 2, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
CompleCure taps AGC for AMDC-based cancer-therapy development
CompleCure taps AGC for AMDC-based cancer-therapy development
Sep 30, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe